CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

122 hedge funds and large institutions have $993M invested in Crinetics Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
–
Holders Change %
0%
% of All Funds
1.97%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
13
Increased
45
Reduced
37
Closed
13
Calls
$43K
Puts
$20K
Net Calls
+$23K
Net Calls Change
-$2.48M

Top Buyers

1
FC
1
Finepoint Capital
Massachusetts
$15.1M
2
PBA
2
Paradigm Biocapital Advisors
New York
$16.3M
3
Millennium Management
3
Millennium Management
New York
$10.5M
4
State Street
4
State Street
Massachusetts
$36.7M
5
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$4.95M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$73.9M
2
BI
2
BVF Inc
California
$50.1M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.5M
4
BBA
4
Baker Bros. Advisors
New York
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$2.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
126
Trexquant Investment
Connecticut
– -$481K -24,509 Closed
Macquarie Group
127
Macquarie Group
Australia
– -$62K -3,138 Closed
CSS
128
Cubist Systematic Strategies
Connecticut
– -$38K -1,925 Closed
AIP
129
Almanack Investment Partners
Pennsylvania
– -$19K -1,001 Closed
LC
130
Lindbrook Capital
California
– -$2K -113 Closed
QT
131
Quantbot Technologies
New York
– -$1K -99 Closed
2 3 4 5
6